\멍게껍질에 함유된 기능성 물질을 효소 및 열수로 추출하여 면역활성 및 항암 효과를 평가하였다. 세포독성을 검정하기 위하여 RAW 264.7 세포주에 추출물을 10∼200 ㎍/㎖ 농도로 처리한 결과 독성을 나타내지 않았다. 따라서 다양한 농도에서 효소 및 열수 추출물의 생리기능성을 평가하기 위하여 NO생성량을 측정한 결과 열수 추출물과 효소 추출물은 높은 NO 생성량을 보였다(123.0~161.7%). 위암 및 대장암 억제효과를 파악하기 위하여 다양한 농도에서 평가하였지만 최대 200 ㎍/㎖ 농도에서도 위암세포 AGS와 대장암세포 HT-29의 세포생장 억제에는 영향을 미치지 못하였다.

이 연구에서는 Yacon 추출물을 분획별 유기용매로 추출하여 항산화 및 항암 활성을 조사하였다. 총 페놀 함량은 ethyl acetate 분획에서 45.53%로 가장 높았고, 전자공여능과 아질산염 소거능의 결과는 ethyl acetate 분획에서 각각 65.20%(100 μg/ml), 91.81% (500 μg/ml), 95.06%(1000 μg/ml)와, 11.71%(100 μg/ml), 36.81%(500 μg/ml), 59.70%(1000 μg/ml)로 모든 농도에서 control 보다 높았다. Xanthine oxidase 저해 활성은 저농도에서 23.74%(100 μg/ml), 43.41%(500 μg/ml)로 control 보다 높은 활성을 보였다. 암세포에 대한 성장 저해 활성 측정 결과 SNU-1에 대해 hexane 분획이 23.75%(10 μg/ml), 34.67%(50 μg/ml), 54.21%(100 μg/ml)로 가장 높은 성장 저해 활성을 보였으며, HeLa에 대해 hexane 분획에서 41.38%(10 μg/ml), 50.53%(50 μg/ml), 60.91%(100 μg/ml), butanol 분획에서 17.05%(10 μg/ml), 43.87%(50 μg/ml), 62.99%(100 μg/ml)로 높은 성장 저해 활성을 보였다 이상의 결과에서 Yacon의 ethyl acetate 분획에서는 항산화 활성, hexane 분획에서는 높은 항암 활성을 볼 수 있었다. 그러므로 각 분획에 따라 항산화 및 항암 활성의 특이성이 있는 것으로 생각되며 각 분획 성분에 따라 기능성 식품으로의 개발과 구체적인 성분에 대한 추가적 연구가 기대된다.

Rubiae radix is root of Runia akane Nakai, it has been used to hemostasis and blood stasis in Korean and China. This study investigated that anti-oxidant and anti-colorectal cancer effect of ERA (ethanol extract of Rubiae radix) and WRA (water extract of Rubiae radix) using RAW 264.7 (murine macrophage from blood) and HCT-116 cells (human colorectal cancer cell line). ERA contained polyphenol (45.77 ± 2.03 ㎎/g) and flavonoid (22.82 ± 1.33 ㎎/g). 500 μM H2O2-induced ROS generation was diminished by 500 ㎍/㎖ ERA treatment in RAW 264.7 cells, but not WRA (125, 250, and 500 ㎍/㎖). Moreover, caspase-3 activity and DNA fragmentation increased by 500 ㎍/㎖ ERA treatment during apoptotic cell death in HCT-116. Results demonstrated that anti-cancer effect of ERA against human colorectal cancer cells is mediated apoptotic cell death and DNA fragmentation through caspase-3 activation. However, further study is required to what active ingredient of ERA are important for anti-oxidant and anti-colorectal cancer effect in vivo.

Background: Mahonia Nepalensis DC. (Hoang lien o ro), the specie of the family Berberidaceae, is widely distributed in the high mountainous areas at altitudes 1700 – 1900 m of Vietnam. It is found that the stem of Mahonia nepalensis indicated anti-inflammatory, anti-bacterial and antifungal activities and they are used particularly for the treatment of eczema, psoriasis, and other skin conditions. However, no study on the antioxidant and anti-cancer activities of Mahonia Nepalensis stem has been previously reported. The aim of this study was to evaluate anti-oxidant and anti-cancer activities of Mahonia Nepalensis stem. Methods and Results: The stem pieces of Mahonia Nepalensis were dried and extracted three times with 100% methanol. After that, the extract was suspended in distilled water and then partitioned with n-hexane, ethyl-acetate (EtOAc) and butanol (water saturated BuOH) fractions were then evaporated using a vacuum rotary evaporator. Evaluation of the anti-oxidative activity of Mahonia Nepalensis was carried out using a DPPH (2,2-diphenyl-1-picrylhydrazyl) radical-producing system. The results revealed that the ethyl acetate fraction of M. nepalensis possessed higher potential DPPH radical scavenging activity (IC50, 81.88 ± 1.33㎍/㎖) than other fractions as well as BHT (2,6-Di-tert-Butyl-4-methylphenol) (IC50, 250.49 ± 1.60㎍/㎖). The reducing power assay was also investigated and EtOAc fraction showed higher absorbance values than other fractions. At 1.0 mg/ml concentration, EtOAc fraction showed absorbance of 1.72, be higher than Ascorbic acid. Cell viability was evaluated according to the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl tetrazolium Bromide) assay. By MTT assay, all fractions showed a significant reduction in cell viability on COLO 205 (Human colon carcinoma cell) at the highest concentration tested (200㎍/ ㎖) with over 70% decrease in cell viability was obtained, and the highest significantly inhibiting effect occurred in butanol fraction with approximately 90% reduction in cell viability. Conclusion: We demonstrated that Mahonia Nepalensis stem extract has highly potential in anti-cancer activity. Further studies are necessary in order to explore the variety of Mahonia Nepalensis stem to be applied as a valuable natural material.

In the present study, the anti-cancer activity of 80% ethanol extracts from 120 kinds of medicinal herbs and native plants were investigated. Among them, the barks of Melia azedarach L. var. japonica Makino showed the highest cytotoxicity in HCT-15 human colon cancer cell. With this result, we carried out hollow fiber (HF) assay and anti-metastasis study to confirm the anti-cancer effects of M. azedarach var. japonica. In MTT assay, M. azedarach var. japonica.inhibited the proliferation of HCT-15 cells in dose-dependent manner. HF assay was carried out using A549 human adenocarcinoma cell, HCT-15 and SK-Hep1 human liver cancer cell via intraperitoneal (IP) and subcutaneous (SC) site. As a results, SK-Hep1 implanted in IP site showed the highest cytotoxicity. The result from metastatic model using B16/BL6 mouse corresponded to that of HF assay. These results suggest that the ethanol extract from M. azedarach var. japonica. might have a potent anti-cancer activity and advanced study is needed for the development of novel natural anti-cancer drug.